Home/Dianthus Therapeutics/Ryan Savitz

RS

Ryan Savitz

Chief Financial Officer

Dianthus Therapeutics

Therapeutic Areas

Autoimmune Diseases Neurology Rare Diseases

Dianthus Therapeutics Pipeline

Drug	Indication	Phase
DNTH103	Generalized Myasthenia Gravis (gMG)	Phase 1
Next-generation complement inhibitors	Undisclosed autoimmune indications	Discovery

Leadership Team at Dianthus Therapeutics

Chief Executive Officer

Simona Skerjanec

Chief Operating Officer

Nenad Tomasevic

Chief Scientific Officer

Chief Medical Officer

View full Dianthus Therapeutics profile